Treatment details
| Prior to ITA initiation | |
| No of IVB injections | |
| 1.25 mg (n=8) | 16 (16, 2–35) |
| 2.0 mg (n=6) | 7 (5, 3–15) |
| 2.5 mg (n=7) | 16 (12, 3–35) |
| 3.0 mg (n=8) | 10 (9, 1–19) |
| IOP (mm Hg) | 12 (12, 10–18) |
| After ITA initiation | |
| No of ITA injections | 7 (7, 3–11) |
| No of IVB injections | 20 (20, 14–27) |
| IOP | 12 (12, 9–19) |
| Months of follow-up | 21 (21, 15–28) |
All values listed as mean (median, range).
IOP, intraocular pressure; ITA, intravitreal triamcinolone acetonide; IVB, intravitreal bevacizumab.